Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/24508
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBradfield, Nicholas I-
dc.contributor.authorEllis, Kathryn A-
dc.contributor.authorSavage, Greg-
dc.contributor.authorMaruff, Paul-
dc.contributor.authorBurnham, Samantha-
dc.contributor.authorDarby, David-
dc.contributor.authorLautenschlager, Nicola T-
dc.contributor.authorMartins, Ralph N-
dc.contributor.authorMasters, Colin L-
dc.contributor.authorRainey-Smith, Stephanie R-
dc.contributor.authorRobertson, Joanne-
dc.contributor.authorRowe, Christopher C-
dc.contributor.authorWoodward, Michael M-
dc.contributor.authorAmes, David-
dc.date2020-08-10-
dc.date.accessioned2020-09-28T20:42:00Z-
dc.date.available2020-09-28T20:42:00Z-
dc.date.issued2021-02-
dc.identifier.citationJournal of the International Neuropsychological Society : JINS 2021; 27(2): 146-157en
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/24508-
dc.description.abstractThe criteria for objective memory impairment in mild cognitive impairment (MCI) are vaguely defined. Aggregating the number of abnormal memory scores (NAMS) is one way to operationalise memory impairment, which we hypothesised would predict progression to Alzheimer's disease (AD) dementia. As part of the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing, 896 older adults who did not have dementia were administered a psychometric battery including three neuropsychological tests of memory, yielding 10 indices of memory. We calculated the number of memory scores corresponding to z ≤ -1.5 (i.e., NAMS) for each participant. Incident diagnosis of AD dementia was established by consensus of an expert panel after 3 years. Of the 722 (80.6%) participants who were followed up, 54 (7.5%) developed AD dementia. There was a strong correlation between NAMS and probability of developing AD dementia (r = .91, p = .0003). Each abnormal memory score conferred an additional 9.8% risk of progressing to AD dementia. The area under the receiver operating characteristic curve for NAMS was 0.87 [95% confidence interval (CI) .81-.93, p < .01]. The odds ratio for NAMS was 1.67 (95% CI 1.40-2.01, p < .01) after correcting for age, sex, education, estimated intelligence quotient, subjective memory complaint, Mini-Mental State Exam (MMSE) score and apolipoprotein E ϵ4 status. Aggregation of abnormal memory scores may be a useful way of operationalising objective memory impairment, predicting incident AD dementia and providing prognostic stratification for individuals with MCI.en
dc.language.isoeng-
dc.subjectCognitive ageingen
dc.subjectCognitive neuroscienceen
dc.subjectMild neurocognitive disorderen
dc.subjectNeurocognitive disordersen
dc.subjectNeuropsychologyen
dc.titleAggregation of Abnormal Memory Scores and Risk of Incident Alzheimer's Disease Dementia: A Measure of Objective Memory Impairment in Amnestic Mild Cognitive Impairment.en
dc.typeJournal Articleen
dc.identifier.journaltitleJournal of the International Neuropsychological Society : JINSen
dc.identifier.affiliationThe Florey Institute of Neurosciences and Mental Health, Parkville, Victoria, Australiaen
dc.identifier.affiliationMolecular Imaging and Therapyen
dc.identifier.affiliationFlorey Institute, The University of Melbourne, Victoria, Australiaen
dc.identifier.affiliationCentre of Excellence for Alzheimer's Disease Research and Care, School of Medical and Health Sciences, Edith Cowan University, Perth, Western Australia, Australiaen
dc.identifier.affiliationNorthWestern Mental Health, Melbourne Health, Parkville, Victoria, Australiaen
dc.identifier.affiliationAcademic Unit for Psychiatry of Old Age, Department of Psychiatry, The University of Melbourne, Parkville, Victoria, Australiaen
dc.identifier.affiliationDepartment of Psychology, Macquarie University, Sydney, NSW, Australiaen
dc.identifier.affiliationSt Vincent's Hospital, Fitzroy, Victoria, Australiaen
dc.identifier.affiliationNational Ageing Research Institute, Parkville, Victoria, Australiaen
dc.identifier.affiliationGeriatric Medicineen
dc.identifier.affiliationCSIRO, Parkville, Victoria, Australiaen
dc.identifier.affiliationCogstate Pty Ltd, Melbourne, Victoria, Australiaen
dc.identifier.doi10.1017/S135561772000079Xen
dc.type.contentTexten
dc.identifier.orcid0000-0002-3340-5296en
dc.identifier.orcid0000-0002-5895-1947en
dc.identifier.pubmedid32772959-
local.name.researcherMasters, Colin L
item.grantfulltextnone-
item.openairetypeJournal Article-
item.languageiso639-1en-
item.fulltextNo Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
crisitem.author.deptThe Florey Institute of Neuroscience and Mental Health-
crisitem.author.deptMolecular Imaging and Therapy-
crisitem.author.deptAged Care-
crisitem.author.deptGeriatric Medicine-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

88
checked on Nov 19, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.